About Ravinder Singh, MD
Dr. Singh is a Board-certified neurologist with extensive clinical and research experience in the treatment and prevention of neurological diseases.
Dr. Singh combines traditional medicine with nutritional education to offer proven natural approaches to disease prevention and optimal health.
Photography by Joann Pecoraro http://www.photographybyjoann.com
- UCLA trained Neurologist
- Past Head of the Stroke Center at King-Drew Medical Center, in Los Angeles
- President Sanare Sanctuary
- President Premier Neurology Medical Group
- Past President of the American Heart Association (AHA), Los Angeles division.
- Certified Stress and Wellness Consultant
- Medical degree in 1989 from St. George’s University, School of Medicine, in Grenada, West Indies.
- Transitional Internship Dept. of Medicine, St. Michael's Medical Center, Newark, New Jersey 1989 - 1990
- Neurology Residency at St. Louis University Hospital, St. Louis, Missouri 1990 - 1992
- Neurology Residency at West LA VA Medical Center/UCLA in Los Angeles, California. 1992 - 1994
- Chief Resident in Neurology In 1993 - 1994
- Recipient of a VA Fellowship grant in Neuroscience and Traumatic Brain Injuries. 1995 - 1998
- Clinical Instructor in Neurology at University of California, Los Angeles (UCLA). 1995 - 1998
- Past Assistant Professor of Neuroscience at Charles R. Drew University of Medicine and Science. 1998 - 2001
- Past Head of the Stroke Center at King-Drew Medical Center, in Los Angeles, California. 1998 - 200
He provides solutions for mastering stress in all aspects of life. These very pragmatic and results-oriented solutions and skills are immediately applicable and geared towards high speed success.
Dr. Singh has given over 100 presentations to the medical community as well as numerous public presentations. In addition, he has conducted seminars on stress management. He has been an invited lecturer and presenter at over 100 hospitals and other related organizations in the US. He has been the featured speaker at the regional board meetings for the AHA, and the spokesperson for the “Train-to-End-Stroke” program.
Dr. Singh has extensive research experience in the acute treatment and prevention of stroke. He was part of the initial thrombolytic (clot-busting drugs) trials using tPA for stroke, and has past and current participation in multiple stroke treatment and prevention trials. He is on staff at Cedars Sinai as a Stroke specialist. In addition, Dr. Singh has extensive research experience in the pharmacological treatment of epilepsy. He has participated in clinical trials of multiple anti-epileptic drugs.